Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias
US-2025090641-A1 · Mar 20, 2025 · US
This page is not indexed by search engines while we improve data quality.
Brainvectis patents
Brainvectis holds 3 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 3 |
| Recent patents | 2 |
| First publication | Nov 14, 2019 |
| Latest publication | Mar 20, 2025 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias
US-2025090641-A1 · Mar 20, 2025 · US
Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias
US-12138298-B2 · Nov 12, 2024 · US
Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias
US-2019343927-A1 · Nov 14, 2019 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 3 |
| Chemistry & Metallurgy | 3 |